Justin Delgado is husband to Kacie Doyle-Delgado, diagnosed at age 11. After more than a decade together, he considers himself to be an expert carb counter and Dexcom inserter. He graduated with his Master of Science in Finance from the University of Utah in 2013 and has been working in commercial banking since then. He attended his first Friends for Life conference in 2015 and is looking forward to volunteering with the teens.
March 15, 2003
School and Daycare
Question from Baltimore, Maryland, USA:
I am a teacher in a behavioral program at a special education center, and I have a student with diabetes and down syndrome. Because of severe behavioral issues, we are exploring the possibility that this student may also have pervasive developmental disorder (PDD) which is commonly treated with stimulant medication. Would a stimulant interfere with insulin treatment? Would a stimulant even be a possibility for us because of his diabetes?
The management of PDD with anti-psychotic drugs does have a risk of significant weight gain and with it insulin resistance. One might expect therefore that treating a child with down syndrome who already has diabetes with this group of drugs might exacerbate the glucose intolerance. At the same time, it is probable that this could be effectively countered by appropriate changes in the management of the diabetes. In other words, it might be that a significant improvement in behaviour might more than offset any increase difficulty in blood sugar control.
[Editor’s comment: Granted the complexity of the situation, it would seem best that the decision to add medications should be jointly made by a pediatric endocrinologist and a behavioral specialist.